Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment
Open Access
- 1 May 2015
- journal article
- research article
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 21 (6) , 653-665
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal LeukoencephalopathyJournal of Immunology Research, 2013
- JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patientsJournal of Translational Medicine, 2012
- JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytesJournal of General Virology, 2012
- JC Virus Latency in the Brain and Extraneural Organs of Patients with and without Progressive Multifocal LeukoencephalopathyJournal of Virology, 2010
- Molecular Regulation of JC Virus Tropism: Insights into Potential Therapeutic Targets for Progressive Multifocal LeukoencephalopathyJournal of Neuroimmune Pharmacology, 2010
- Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesisThe Lancet Neurology, 2010
- Determinants of survival in progressive multifocal leukoencephalopathyNeurology, 2009
- Asymptomatic Reactivation of JC Virus in Patients Treated with NatalizumabNew England Journal of Medicine, 2009
- Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cellsNeurology, 2009
- Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individualsJournal of Medical Virology, 2008